ResearcherUniversity of CalgaryNo recent work listed

Vincent Channing Tam

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8732-0530; OpenAlex author ID A5080776657. Sources: OpenAlex.

Their work

Papers: 3 (first author 1, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 3

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Paige T Shelemey · 1 shared paper, 2021 · strength 0.17
- Paper Metastatic pancreatic cancer with complete response to FOLFIRINOX treatment. DOI 10.1136/bcr-2020-238395 ↗
Kelvin Chan · 2 shared papers, 2013–2015 · strength 0.10
- Paper Impact of country-specific EQ-5D-3L tariffs on the economic value of systemic therapies used in the treatment of metast… DOI 10.3747/co.22.2592 ↗
- Paper Cost-effectiveness of systemic therapies for metastatic pancreatic cancer. DOI 10.3747/co.20.1223 ↗
Y.J. Ko · 2 shared papers, 2013–2015 · strength 0.10
- Paper Impact of country-specific EQ-5D-3L tariffs on the economic value of systemic therapies used in the treatment of metast… DOI 10.3747/co.22.2592 ↗
- Paper Cost-effectiveness of systemic therapies for metastatic pancreatic cancer. DOI 10.3747/co.20.1223 ↗
Kelly Lien · 1 shared paper, 2015 · strength 0.06
- Paper Impact of country-specific EQ-5D-3L tariffs on the economic value of systemic therapies used in the treatment of metast… DOI 10.3747/co.22.2592 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.